Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Zinforo (ceftaroline fosamil) receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia
-
New data show investigational compound dapagliflozin demonstrated significant reductions in blood sugar levels when added to sitagliptin in adults with type 2 diabetes at 24 weeks, with results maintained over 48 weeks
-
Innovative public-private collaboration launches to tackle antibiotic research
-
AstraZeneca PLC First quarter results 2012
-
David Brennan to retire as AstraZeneca’s Chief Executive Officer
-
AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
-
AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash) including lead product lesinurad in Phase III development for gout
-
FORXIGA (dapagliflozin) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
-
AstraZeneca and Amgen announce collaboration to jointly develop and commercialise clinical-stage inflammation portfolio
-
US District Court finds SEROQUEL XR® formulation patent valid and infringed
Latest articles and press releases
All of our latest press releases and articles are available to explore
